The Moon Shots Program is enabled by cross-cutting platforms that bring together the best attributes of both academia and industry. These platforms are staffed by cross-functional, professional teams charged with converting current knowledge into drugs, tests, devices and policies that can benefit patients as quickly as possible.

APOLLO (Adaptive Patient Oriented Longitudinal Learning and Optimization)

APOLLO establishes and optimizes workflows to seamlessly integrate research activities into patient care so that longitudinal clinical and research data can be generated, collected and aggregated efficiently to accelerate the discovery of new insights and translation of these insights into new cancer treatments and care strategies. Learn more...

Lynda Chin, M.D.
Chair, Genomic Medicine and Scientific Director, Institute for Applied Cancer Science
Andrew Futreal, Ph.D.
Professor, Genomic Medicine

Big Data Analytics

This platform establishes an information technology environment that enables centralization, integration and secured access of patient and research data as well as analytical infrastructure that powers clinical decision support. Learn more...

John Frenzel, M.D.
Professor, Anesthesiology & Perioperative Medicine and Chief Medical Information Officer
Keith Perry
Associate Vice President and Deputy Chief Information Officer

Cancer Prevention and Control

The cancer prevention and control platform develops and delivers comprehensive, evidence-based strategies in cancer prevention, screening, early detection and survivorship to achieve a measureable and lasting reduction in the cancer burden. Learn more...

Ernest Hawk, M.D.
Vice President, Cancer Prevention
Mark Moreno
Vice President, Government Relations

Center for Co-Clinical Trials

The center accelerates the in vivo preclinical evaluation of drugs to position them for success in early-stage clinical trials in specific patient populations. Learn more...

Carlo Toniatti, M.D., PH.D.
Head of Research, Institute for Applied Cancer Science
Tim Heffernan, PH.D.
Senior Associate Director, Institute for Applied Cancer Science


The immunotherapy platform enables the design of pre-clinical studies and clinical trials to evaluate novel immunotherapy agents as monotherapy or in combination, employing validated biomarkers and immune monitoring strategies. Learn more...

James Allison, Ph.D.
Chair, Immunology
Patrick Hwu, M.D.
Chair, Melanoma Medical Oncology
Padmanee Sharma, M.D., PH.D.
Associate Professor, Genitourinary Medical Oncology

Institute for Applied Cancer Science

The institute develops novel, safe and effective drug candidates suitable for progression into clinical studies in specific patient populations. Learn more...

Giulio Draetta, M.D., Ph.D.
Professor, Genomic Medicine and Director, Institute for Applied Cancer Science
Lynda Chin, M.D.
Chair, Genomic Medicine and Scientific Director, Institute for Applied Cancer Science


This platform implements in-depth quantitative proteomics profiling technologies to develop diagnostics for early detection as well prognostic and predictive markers and to discover new targets for therapeutics. Learn more...

Sam Hanash, M.D, Ph.D.
Professor of Clinical Cancer Prevention Research